Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 to 45

How changes in brain blood flow affect breathing during sleep

Official title: Role of Cerebral Blood Flow on Ventilatory Stability During Sleep in Normoxia and Intermittent Hypoxia

Run by University of Calgary · NCT03255408 · Data updated 2026-11-12

This project will test whether temporarily lowering blood flow to the brain changes how healthy adults' breathing responds to low oxygen and high carbon dioxide during normal sleep and short periods of low oxygen.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment12 (estimated)
SponsorUniversity of Calgary
Academic / other
Locations1 site (Calgary, Alberta)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedMay 1, 2026
Trial IDNCT03255408 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–45 living in Calgary for at least one year who are non-smokers, not pregnant or obese, free of major cardiovascular, cerebrovascular, renal, or metabolic disease, not taking blood pressure medications, and not lactose intolerant.

Probably not a fit

People with obstructive sleep apnea, obesity, pregnancy, smoking history, major chronic diseases, or those taking blood pressure medications are excluded and unlikely to receive direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, placebo-controlled crossover study uses a drug to lower cerebral blood flow and compares ventilatory chemoreflexes before, during, and after sleep under normal oxygen and isocapnic intermittent hypoxia. Participants will sleep under both conditions in random order with washout periods between sessions while investigators measure acute ventilatory responses to hypoxia (AHVR) and hypercapnia (HCVR). Cerebral blood flow will be pharmacologically manipulated in randomized order against placebo, and venous blood and urine samples will be collected for vascular biomarkers. All procedures are performed at a single center (University of Calgary) in healthy adults aged 18–45.

Why it matters

Potential benefit: If successful, findings could clarify how brain blood flow influences breathing control during sleep and guide strategies to protect breathing in people at risk for sleep-disordered breathing or cerebrovascular events.

How similar studies have gone: Prior physiological studies have examined cerebral blood flow and ventilatory chemoreflexes in short-term settings, but combining pharmacological CBF lowering with isocapnic intermittent hypoxia during sleep is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy adults
* 18 - 45 years of age
* Living in Calgary for the past one year
* Have no medical condition or should not be taking any blood pressure medications.
* The participant should not be lactose intolerant

Exclusion Criteria:

* Cerebrovascular, cardio-respiratory, renal and metabolic diseases
* Bleeding disorders and upper gastrointestinal diseases e.g. peptic ulcer disease
* Pregnancy, obese and sleep-disordered breathing
* Drug allergies to non-steroidal anti-inflammatories
* Currently smoking

Where it's running

  • University of Calgary
    Calgary, Alberta, Canada
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Portable MRI for kids with hypoxic brain injury

    This study tests whether a bedside, low-field portable MRI can accurately detect hypoxic-ischemic brain injuries in children compared with standard imaging.

    Recruiting Children's Mercy Hospital Kansas City · Kansas City, Missouri · NCT07577336

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • Exploring the link between blood pressure and cognitive decline after stroke

    This study looks at how blood pressure levels might affect thinking and memory problems in people who have had a stroke.

    Recruiting First Affiliated Hospital of Chongqing Medical University · Chongqing, Chongqing Municipality · NCT06730711

  • Registry of patients with sleep disorders

    This study is collecting information from people with sleep disorders to see how these conditions affect their lives and to track their progress over time.

    Recruiting Johannes Gutenberg University Mainz · Mainz, Rhineland-Palatinate · NCT05321355

  • Inspiratory muscle training to lower blood pressure in postmenopausal women

    This study is testing if a special breathing exercise can lower blood pressure more effectively than regular walking in postmenopausal women with high blood pressure.

    Recruiting University of Colorado, Boulder · Boulder, Colorado · NCT05000515

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.